The new partnership combines Weight Watchers’ scientifically-backed medical and behavioral expertise with PVOLVE’s clinically-studied method to support members at every age and stage of lifeNEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced a strategic partnership with PVOLVE, the clinically validated workout method, designed to support longevity through strength, mobility, and stability trai ...

Group 1: Kingdom Capital Advisors Performance - Kingdom Capital Advisors achieved a 17.45% return net of fees in 2025, despite facing significant challenges including a bankruptcy and a cyberattack [1] - The composite return for the fourth quarter was 8.88% net of fees, outperforming the Russell 2000 TR (2.19%), S&P 500 TR (2.68%), and NASDAQ 100 TR (2.47%) [1] Group 2: WW International, Inc. (NASDAQ:WW) Overview - WW International, Inc. (NASDAQ:WW) experienced a one-month return of 35.07% and a year-to-date gain of 17.85% over the past three months, with a market capitalization of $343.85 million as of January 8, 2026 [2] - Both WW International, Inc. and Magnera (MAGN) contributed positively to the fourth quarter returns, despite being year-to-date detractors [3] Group 3: Hedge Fund Interest and Investment Outlook - WW International, Inc. is held by 18 hedge fund portfolios at the end of the third quarter, but it is not among the 30 most popular stocks among hedge funds [4] - The company is acknowledged for its investment potential, but certain AI stocks are considered to offer greater upside potential and less downside risk [4]

Core Insights - WW International, Inc. (Weight Watchers) is participating in several investor conferences in January 2026, indicating active engagement with the investment community [1][2] Company Overview - Weight Watchers is recognized as the global leader in science-backed weight management, leveraging over 60 years of experience to provide a comprehensive support system that integrates scientific expertise, medication, technology, and community support [1] - The company offers a personalized approach to weight management, including access to GLP-1 medications and U.S.-based clinical interventions, distinguishing itself from competitors with a focus on research and empathy [1] Upcoming Events - The company will host meetings with investors at the ICR Conference in Orlando, FL on January 12-13, 2026 [2] - A virtual fireside chat is scheduled for January 14, 2026, at 11:00 a.m. ET, which will be accessible via live audio webcast on the company's corporate website, with a replay available for at least 90 days [2]

Core Viewpoint - WW International is integrating GLP-1 weight-loss drugs into its offerings, aiming to enhance its weight management services following a restructuring and bankruptcy filing [1][4]. Group 1: Company Overview - WW International, known as Weight Watchers, is a global leader in weight management and wellness support, providing science-backed programs for healthy habits through personalized coaching and community connections [3]. - The company has a market capitalization of $263.85 million [3]. Group 2: Financial Performance - WW reported a 10.8% year-over-year decline in revenues for the third quarter of fiscal 2025, totaling $172.09 million, which exceeded Wall Street's expectations of $161.40 million [7]. - The stock has experienced a decline of 13.09% over the past three months but gained 0.77% in the last five days, indicating potential positive momentum from its new GLP-1 strategy [5]. Group 3: Stock Performance - WW's stock gained 12.1% intraday on December 16 following the announcement of its new platform integrating GLP-1 medications [2]. - The stock is currently trading at a price-to-earnings ratio of 1.50x, significantly lower than the industry average of 20.25x, suggesting it is undervalued compared to peers [6].

Core Insights - WW International, Inc. (Weight Watchers) has launched a new integrated experience that combines GLP-1 prescribing, personalized nutrition, behavioral support, coaching, and community within a redesigned app [1][2] - The new offering aims to provide coordinated, evidence-based support to help members achieve and sustain superior weight management results [1][2] GLP-1 Program and Support - Weight Watchers Med+ is a dedicated GLP-1 medical program that connects members with board-certified physicians who specialize in obesity and metabolic health, providing prescriptions and ongoing medical guidance [3] - The GLP-1 Success program offers personalized nutrition guidance, tools for tracking weight loss and medication doses, and strategies for managing side effects, enhancing the effectiveness of GLP-1 medications [4][5] - Over 70% of Weight Watchers Med+ members on the GLP-1 Success Program report that it helps minimize side effects from weight loss medications [4] Digital Experience and Tools - The new digital experience includes the Weight Health Score, an evidence-based metric that helps members track their daily habits and progress [6][7] - An AI-powered body scanner provides insights into changes in fat and muscle mass, which is particularly beneficial for members using GLP-1 medications [7][8] - Members will have access to exclusive fitness content and can choose from different modes that adjust support levels based on their weight management journey [9][10] Community and Coaching - Weight Watchers emphasizes the importance of community support, offering small, coach-led groups focused on various topics, including GLP-1 use and nutrition [12][13] - The company is expanding its virtual experience and curated programming to enhance community support for members [12] Brand Evolution - Weight Watchers is introducing a refreshed brand identity that reflects its evolution and commitment to integrated, evidence-based weight management solutions [14][15] - The new branding aims to convey stability, trust, and a focus on sustainable health outcomes, aligning with the company's mission to support members in their weight management journeys [15][16] Availability - The new integrated experience will be rolled out globally starting December 26, with the Weight Watchers app available on both iOS and Android platforms [16]

Core Insights - Weight Watchers has launched a new integrated experience that combines GLP-1 prescriptions with personalized nutrition, coaching, and community support to enhance weight management and long-term health outcomes [1][15][18] Group 1: New Offerings - The new Weight Watchers Med+ program provides members access to board-certified physicians who specialize in obesity and metabolic health, offering GLP-1 prescriptions and ongoing medical guidance [3] - The GLP-1 Success program includes personalized nutrition guidance, tools for tracking weight loss and medication doses, and strategies for managing side effects, aiming to improve outcomes beyond medication alone [4][5] - Members using GLP-1s in conjunction with Weight Watchers report greater weight loss and higher satisfaction, with 90% expressing interest in community support programs [2] Group 2: Digital Experience Enhancements - A redesigned digital platform features the Weight Health Score, an evidence-based metric that helps members track their daily habits and progress [7] - An AI-powered body scanner provides insights into changes in fat and muscle mass, which is particularly beneficial for members using GLP-1 medications [7] - The app will include exclusive fitness content and flexible modes that adjust support levels based on members' weight management phases [6][8] Group 3: Community and Support - Weight Watchers emphasizes the importance of community support, offering small, coach-led groups focused on various topics, including GLP-1 use and nutrition [10][11] - The company is expanding its virtual experience to enhance member connection and support, building on its 62-year legacy of community engagement [10][12] Group 4: Brand Evolution - Weight Watchers is introducing a refreshed brand identity that reflects its integrated, evidence-based approach to weight management [12][16] - The new branding aims to convey stability and trust, aligning with the company's commitment to sustainable health outcomes [16][17]

Core Insights - WW International, Inc. reported total revenues of $172 million for Q3 2025, with clinical subscription revenues reaching $26 million, reflecting a year-over-year increase of 35% [1][4][11] - The company experienced a net loss of $58 million, resulting in a net loss margin of 33.4%, while adjusted EBITDA was $43 million, yielding an adjusted EBITDA margin of 24.9% [1][11] - The company has narrowed its full-year fiscal 2025 guidance to the higher end of previous ranges, projecting revenues of $695 million to $700 million and adjusted EBITDA of $145 million to $150 million [5][12][11] Financial Performance - Total revenues decreased by 10.8% year-over-year, with subscription revenues netting $170.9 million, down from $191.2 million [11][34] - Clinical subscription revenues grew by 35.3% year-over-year, while behavioral subscription revenues fell by 15.7% [11][34] - The company’s adjusted EBITDA margin of 24.9% reflects disciplined cost management despite the decline in total revenues [4][11] Strategic Positioning - The CEO emphasized the company's unique position at the intersection of medical innovation and behavioral science, aiming to lead in the evolving weight health market [4] - The CFO noted a healthier balance sheet, allowing for investments in growth opportunities while maintaining strong profitability [4] - Key initiatives launched include a new menopause program and advancements in brand, digital, and clinical innovation [11] Subscriber Metrics - Incoming subscribers totaled 3,167, a decrease of 17.4% compared to the previous year, with end-of-period subscribers at 2,986, down 18.6% [41] - Monthly subscription revenues per average subscriber increased by 9.0% to $18.52 [41] Balance Sheet Strength - The company reported a significant reduction in total debt by over 70%, amounting to approximately $1.1 billion, with cash at the end of the quarter increasing to $170 million from $152 million [11][22]

Core Insights - WW International, Inc. (WeightWatchers) will announce its third quarter 2025 results on November 6, 2025, before market opening [1] - A conference call to discuss the results will take place at 8:30 a.m. ET on the same day, with a webcast available on the company's corporate website [2] Company Overview - WeightWatchers is a leader in science-backed weight management, providing an integrated support system that combines scientific expertise with human connection [3] - The company has over 60 years of experience and is recognized as the most studied commercial weight management program globally, featuring a U.S. doctor-recommended weight-loss program [3] - WeightWatchers offers a holistic and personalized approach, including clinical interventions and a global network of coaches, aimed at helping members achieve and sustain their health goals [3]

Core Insights - WW International, Inc. has announced a collaboration with Amazon Pharmacy to enhance access to weight management medications for WeightWatchers Clinic members [1][5] - The partnership aims to simplify the process of obtaining medications, providing real-time availability, automatic savings, and reliable home delivery [2][3] Collaboration Details - WeightWatchers Clinic members can now check medication availability, compare delivery times, and utilize Amazon Pharmacy for prescriptions, improving convenience [2][4] - Amazon Pharmacy will automatically apply manufacturer-sponsored savings at checkout, eliminating the need for manual coupon entry [3][4] Service Enhancements - The collaboration leverages Amazon's logistics for fast and reliable delivery, including free two-day shipping for Prime members and same-day delivery in eligible areas [3][4] - WeightWatchers emphasizes a holistic approach, combining medication access with nutrition programs and community support to enhance member outcomes [6] Performance Metrics - A recent study indicated that WeightWatchers Clinic members lost an average of 21% of their body weight over 12 months, surpassing results from other telehealth providers and clinical trials [6] Company Background - WeightWatchers is recognized as a leader in science-backed weight management, with over 60 years of experience and a comprehensive support system [7] - The company offers a personalized approach that includes clinical interventions and a global network of coaches, aiming to provide sustainable health outcomes for its members [7]

Core Insights - WeightWatchers has launched the WeightWatchers RxFlexFund, a unique solution that combines direct pricing from pharmaceutical manufacturers with flexible employer subsidy coverage for GLP-1 medications, integrated with comprehensive behavioral and clinical support [1][2][4] Company Overview - WeightWatchers is recognized as the global leader in science-backed weight management, offering a holistic support system that includes clinical interventions, medications, and community support [6] Product Offering - The WeightWatchers RxFlexFund allows employers to cover a percentage of GLP-1 medication costs, ranging from 25% to 75%, while providing access to WeightWatchers' full-spectrum behavioral care, including FDA-approved GLP-1 medications and nutritional support [2][3] Clinical Impact - The program aims to reduce annual healthcare expenses by 20% for individuals with chronic conditions who lose weight, transitioning from obesity to overweight, and has shown a 46% improvement in work-related quality of life among clinical trial participants [4][5] Employer Benefits - The RxFlexFund provides employers with a predictable way to offer GLP-1 access, reducing the complexity of traditional coverage models and potentially leading to increased productivity, job satisfaction, and reduced absenteeism [4][5] Strategic Positioning - WeightWatchers RxFlexFund redefines the access to GLP-1 treatments, balancing affordability and access while maintaining medical responsibility and long-term behavior change support [5]